Control of Acinetobacter Outbreaks with Oral Polymyxin

  • M. Sánchez
  • M. Álvarez
Conference paper
Part of the Topics in Anaesthesia and Critical Care book series (TIACC)


Acinetobacter (A.) baumannii has emerged in recent years as an important nosocomial pathogen, both because it frequently causes severe infections [1, 2] with multidrug-resistant strains [3–8], and because it is involved in multiple epidemic outbreaks in intensive care units (ICU) [9–13] and general hospital wards [4, 10, 14, 15]. In spite of intense efforts to control and prevent colonization and infection, A. baumannii has become endemic in ICU in Spain [10, 16–18] and many other countries [2–4, 8, 9, 15, 19–21].


Nosocomial Pneumonia Acinetobacter Baumannii Selective Digestive Decontamination Selective Decontamination Colonization Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bergogne-Berezin E, Towner KJ (1996) Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9: 148–165PubMedPubMedCentralGoogle Scholar
  2. 2.
    Fagon JY, Chastre J, Domart Y et al (1996) Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis 23: 538–542PubMedCrossRefGoogle Scholar
  3. 3.
    Sader HS, Jones RN, Gales AC et al (1998) Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. Diagn Microbiol Infect Dis 32: 289–301Google Scholar
  4. 4.
    Go ES, Urban C, Burns J et al (1994) Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344: 1329–1332PubMedCrossRefGoogle Scholar
  5. 5.
    Lopez-Hernandez S, Alarcon T, Lopez-Brea M (1998) Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain. Eur J Clin Microbiol Infect Dis 17: 282–285PubMedCrossRefGoogle Scholar
  6. 6.
    Levin AS, Barone AA, Penco J et al (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28: 1008–11PubMedCrossRefGoogle Scholar
  7. 7.
    Ruiz J, Nunez ML, Perez J et al (1999) Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Eur J Clin Microbiol Infect Dis 18: 292–529PubMedCrossRefGoogle Scholar
  8. 8.
    Lyytikainen O, Koljalg S, Harma M, Vuopio VJ (1995) Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem. J Hosp Infect 31: 41–54PubMedCrossRefGoogle Scholar
  9. 9.
    Wisplinghoff H, Perbix W, Seifert H (1999) Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients. Clin Infect Dis 28: 59–66.PubMedCrossRefGoogle Scholar
  10. 10.
    Cisneros JM, Reyes MJ, Pachon J et al (1996) Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 22: 1026–1032PubMedCrossRefGoogle Scholar
  11. 11.
    Timsit JF, Garrait V, Misset B et al (1993) The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients. J Infect Dis 168: 1336–1337PubMedCrossRefGoogle Scholar
  12. 12.
    Corbella X, Pujol M, Ayats J et al (1996) Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 23: 329–234PubMedCrossRefGoogle Scholar
  13. 13.
    Corbella X, Pujol M, Argerich MJ et al (1999) Environmental sampling of Acinetobacter baumannii: moistened swabs versus moistened sterile gauze pads [letter]. Infect Control Hosp Epidemiol 20: 458–60PubMedCrossRefGoogle Scholar
  14. 14.
    McDonald LC, Walker M, Carson L et al (1998) Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners. Pediatr Infect Dis J 17: 716–722PubMedCrossRefGoogle Scholar
  15. 15.
    Siau H, Yuen KY, Ho PL et al (1999) Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infect Dis 28: 26–30PubMedCrossRefGoogle Scholar
  16. 16.
    Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J et al (1999) Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 27: 1794–1799PubMedGoogle Scholar
  17. 17.
    Ayats J, Corbella X, Ardanuy C et al (1997) Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 37: 287–295PubMedCrossRefGoogle Scholar
  18. 18.
    Garcia-Arata MI, Alarcon T, Lopez-Brea M (1996) Emergence of resistant isolates of Acinetobacter calcoaceticus-A. baumannii complex in a Spanish hospital over a five-year period. Eur J Clin Microbiol Infect Dis 15: 512–515PubMedCrossRefGoogle Scholar
  19. 19.
    Siau H, Yuen KY, Wong SS et al (1996) The epidemiology of acinetobacter infections in Hong Kong. J Med Microbiol 44: 340–347PubMedCrossRefGoogle Scholar
  20. 20.
    Webster CA, Crowe M, Humphreys H, Towner KJ (1998) Surveillance of an adult intensive care unit for long-term persistence of a multi-resistant strain of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 17: 171–176PubMedGoogle Scholar
  21. 21.
    Lortholary O, Fagon JY, Hoi AB et al (1995) Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 20: 790–796PubMedCrossRefGoogle Scholar
  22. 22.
    Fagon JY, Chastre J, Hance AJ et al (1993) Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94: 281–288PubMedCrossRefGoogle Scholar
  23. 23.
    Garrouste-Orgeas M, Marie O, Rouveau M et al (1996) Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality. J Hosp Infect 34: 279–289PubMedCrossRefGoogle Scholar
  24. 24.
    Chu YW, Leung CM, Houang ET et al (1999) Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 37: 2962–2967PubMedPubMedCentralGoogle Scholar
  25. 25.
    Seifert H, Dijkshoorn L, Gerner-Smidt P et al (1997) Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 35: 2819–2825PubMedPubMedCentralGoogle Scholar
  26. 26.
    Garrouste-Orgeas M, Chevret S, Arlet G et al (1997) Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 156: 1647–1655Google Scholar
  27. 27.
    van Saene HK, Damjanovic V, Murray AE, de la Cal MA (1996) How to classify infections in intensive care units-the carrier state, a criterion whose time has come? J Hosp Infect 33: 1–12Google Scholar
  28. 28.
    Sanchez M, Mir N, Canton R et al (1997) The incidence of endogenous gram-positive infections (E-GPI) in critically ill patients (Pts) receiving topical vancomicin (V). A randomized, double-blind, placebo-controlled study. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy ( ICAAC ); Toronto [Abstract]Google Scholar
  29. 29.
    Sanchez M, Mir N, Canton R et al (1997) The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant staphylococcus aureus in critically ill patients (Pts). A double-blind, randomized, placebo-controlled study. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada [Abstract]Google Scholar
  30. 30.
    Bergmans DC, Bonten MJ, Stobberingh EE et al (1998) Colonization with Pseudomonas aeruginosa in patients developing ventilator-associated pneumonia. Infect Control Hosp Epidemiol 19: 853–855PubMedCrossRefGoogle Scholar
  31. 31.
    Bonten MJ, Hayden MK, Nathan C et al (1996) Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348: 1615–1619PubMedCrossRefGoogle Scholar
  32. 32.
    Pittet D, Monod M, Filthuth I et al (1991) Contour-clamped homogeneous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med 91: 256S - 263SPubMedCrossRefGoogle Scholar
  33. 33.
    Struelens MJ, Carlier E, Maes N et al (1993) Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. J Hosp Infect 25: 15–32PubMedCrossRefGoogle Scholar
  34. 34.
    Koljalg S, Sults I, Raukas E et al (1999) Distribution of Acinetobacter baumannii in a neurointensive care unit. Scand J Infect Dis 31: 145–150PubMedCrossRefGoogle Scholar
  35. 35.
    Toltzis P, Yamashita T, Vilt L et al (1998) Antibiotic restriction does not alter endemic colonization with resistant gram-negative rods in a pediatric intensive care unit. Crit Care Med 26: 1893–1899PubMedGoogle Scholar
  36. 36.
    Goldmann DA, Weinstein RA, Wenzel RP et al (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 275: 234–240Google Scholar
  37. 37.
    Shlaes DM, Gerding DN, John JFJ et al (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals [see comments]. Clin Infect Dis 25: 584–99PubMedCrossRefGoogle Scholar
  38. 38.
    Villers D, Espaze E, Coste-Burel M et al (1998) Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 129: 182–189PubMedCrossRefGoogle Scholar
  39. 39.
    D’Agata EMC,Venkatraman L, DeGirolami Pet al (1999) Colonization with broad-spectrum cephalosporin-resistant Gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Crit Care Med 27: 1090–1095Google Scholar
  40. 40.
    Husni RN, Goldstein LS, Arroliga AC et al (1999) Risk factors for an outbreak of multidrug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 115: 1378–1382PubMedCrossRefGoogle Scholar
  41. 41.
    Bergmans DC, Bonten MJ, van Tiel FH et al (1998) Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit. Thorax 53: 1053–1058PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    D’Agata EM, Venkataraman L, DeGirolami P, Samore M (1999) Molecular epidemiology of ceftazidime-resistant gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods. J Clin Microbiol 37: 3065–3067PubMedPubMedCentralGoogle Scholar
  43. 43.
    Marques MB, Waites KB, Mangino JE et al (1997) Genotypic investigation of multidrugresistant Acinetobacter baumannii infections in a medical intensive care unit. J Hosp Infect 37: 125–35PubMedCrossRefGoogle Scholar
  44. 44.
    Arpin C, Coze C, Rogues AM et al (1996) Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J Clin Microbiol 34: 2163–2169PubMedPubMedCentralGoogle Scholar
  45. 45.
    Cardoso CL, Pereira HH, Zequim JC, Guilhermetti M (1999) Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Am J Infect Control 27: 327–331PubMedCrossRefGoogle Scholar
  46. 46.
    Jawad A, Seifert H, Snelling AM et al (1998) Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 36: 1938–1941PubMedPubMedCentralGoogle Scholar
  47. 47.
    Pittet D, Dharan S, Touveneau S et al (1999) Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 159: 821–826PubMedCrossRefGoogle Scholar
  48. 48.
    Pittet D, Mourouga P, Perneger TV (1999) Compliance with handwashing in a teaching hospital. Ann Intern Med 130: 126–130PubMedCrossRefGoogle Scholar
  49. 49.
    De Gheldre Y, Maes N, Rost F et al (1997) Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol 35: 152–160PubMedPubMedCentralGoogle Scholar
  50. 50.
    Brun-Buisson C, Legrand P, Rauss A et al (1989) Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 110: 873–881Google Scholar
  51. 51.
    Taylor ME, Oppenheim BA (1991) Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 17: 271–278PubMedCrossRefGoogle Scholar
  52. 52.
    Riley TV, Webb SA, Cadwallader H et al (1996) Outbreak of gentamicin-resistant Acinetobacter baumanii in an intensive care unit: clinical, epidemiological and microbiological features. Pathology 28: 359–363PubMedCrossRefGoogle Scholar
  53. 53.
    Bonten MJ, Slaughter S, Ambergen AW et al (1998) The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 158: 1127–1132PubMedCrossRefGoogle Scholar
  54. 54.
    Bonten MJ, Gaillard CA, Johanson WGJ et al (1994) Colonization in patients receiving and not receiving topical antimicrobial prophylaxis. Am J Respir Crit Care Med 150: 1332–1340PubMedGoogle Scholar
  55. 55.
    Stoutenbeek CP, van Saene HK, Zandstra DF (1987) The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother 19: 513–20PubMedCrossRefGoogle Scholar
  56. 56.
    Ledingham IM, Alcock SR, Eastaway AT et al (1988) Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1: 785–790PubMedCrossRefGoogle Scholar
  57. 57.
    Hammond JM, Potgieter PD, Saunders GL, Forder AA (1992) Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 340: 5–9PubMedCrossRefGoogle Scholar
  58. 58.
    Sanchez Garcia M, Cambronero Galache JA, López Díaz J et al (1998) Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 158: 908–916Google Scholar
  59. 59.
    Cornaglia G, Riccio’ML, Mazzariol A et al (1999) Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet 353: 899–900PubMedCrossRefGoogle Scholar
  60. 60.
    Lopez-Hernandez S, Alarcon T, Lopez-Brea M (1998) Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain. Eur J Clin Microbiol Infect Dis 17: 282–285PubMedCrossRefGoogle Scholar
  61. 61.
    Brown S, Bantar C, Young HK, Amyes SG (1998) Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2. Lancet 351: 186–187 [letter]Google Scholar
  62. 62.
    Kurokawa H, Yagi T, Shibata N et al (1999) Worldwide proliferation of carbapenemresistant gram-negative bacteria. Lancet 354: 955 [letter]Google Scholar
  63. 63.
    Hammond JM, Potgieter PD (1995) Long-term effects of selective decontamination on antimicrobial resistance [see comments]. Crit Care Med 23: 637–645PubMedGoogle Scholar
  64. 64.
    Hancock RE (1997) Peptide antibiotics. Lancet 349: 418–422PubMedCrossRefGoogle Scholar
  65. 65.
    Catchpole CR, Andrews JM, Brenwald N, Wise R (1997) A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 39: 255–260PubMedCrossRefGoogle Scholar
  66. 66.
    Lortholary O, Fagon JY, Buu HA et al (1998) Colonization by Acinetobacter baumanii in intensive-care-unit patients. Infect Control Hosp Epidemiol 19: 188–190PubMedCrossRefGoogle Scholar
  67. 67.
    Aerdts SJ, van Dalen R, Clasener HA et al (1991) Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients. A prospective, blinded, randomized trial of the effect of a novel regimen. Chest 100: 783–791Google Scholar
  68. 68.
    Winter R, Humphreys H, Pick A et al (1992) A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. J Antimicrob Chemother 30: 73–87PubMedCrossRefGoogle Scholar
  69. 69.
    Ferrer M, Torres A, Gonzalez J et al (1994) Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 120: 389–395PubMedCrossRefGoogle Scholar
  70. 70.
    Verwaest C, Verhaegen J, Ferdinande P et al (1997) Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 25: 63–71PubMedGoogle Scholar
  71. 71.
    Ulrich C, Harinck-de Weerd JE, Bakker NC et al (1989) Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective randomized study. Intensive Care Med 15: 424–431PubMedCrossRefGoogle Scholar
  72. 72.
    Hartenauer U, Thulig B, Lawin P, Fegeler W (1990) Infection surveillance and selective decontamination of the digestive tract (SDD) in critically ill patients-results of a controlled study. Infection 18 [Suppl 1]: S22 - S30PubMedCrossRefGoogle Scholar
  73. 73.
    Luiten EJ, Hop WC, Lange JF, Bruining HA (1995) Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 222: 57–65PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Korinek AM, Laisne MJ, Nicolas MH et al (1993) Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 21: 1466–1473PubMedGoogle Scholar
  75. 75.
    Rocha LA, Martin MJ, Pita S et al (1992) Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study. Intensive Care Med 18: 398–404Google Scholar

Copyright information

© Springer-Verlag Italia, Milano 2001

Authors and Affiliations

  • M. Sánchez
  • M. Álvarez

There are no affiliations available

Personalised recommendations